SCHEMBL7025005

SCHEMBL7025005

c1ccc2[nH]c(-c3nnn[nH]3)nc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.68
RAB9A P51151 11/20 0.68
ALDH1A1 P00352 11/20 0.68
KDM4E B2RXH2 9/20 0.68
SMN1; SMN2 Q16637 9/20 0.68
HSD17B10 Q99714 7/20 0.68
PKM P14618 4/20 0.68
TP53 P04637 3/20 0.68
NPSR1 Q6W5P4 3/20 0.68
ABCB11 O95342 1/20 0.68
BTK Q06187 1/20 0.56
GAA P10253 2/20 0.55
AURKA O14965 1/20 0.51
CDK1 P06493 1/20 0.51
CDK2 P24941 1/20 0.51
AURKB Q96GD4 1/20 0.51
PKN1 Q16512 1/20 0.50
PKN2 Q16513 1/20 0.50
FGFR1 P11362 1/20 0.50
FLT1 P17948 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL172216 0.82 NPC1 (1.00) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL30634854 0.82 NPC1 (1.00) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL30561047 0.82 NPC1 (1.00) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
Water SCHEMBL9817804 0.80 NPC1 (0.95) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10699127 0.77 TNKS (0.61) NPC1RAB9AALDH1A1KDM4EHSD17B10
SCHEMBL9590371 0.75 MGAM (0.40) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL9590411 0.75 NPC1 (0.35) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL28565064 0.74 ALDH1A1 (0.61) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL28579176 0.74 ALDH1A1 (0.60) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL2178266 0.72 NPC1 (0.88) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 EP disclosed
EP-1206260-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-10-30 EP disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206260-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 US disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
WO-2001000207-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
US-5216003-A Antihypoxic, antiischemic agents G. D. SEARLE & CO. (US) 1993-06-01 US disclosed
US-4213986-A DERIVATIVES CONTAIN TETRAZOLE RING, TREATMENT OF PURINE METABOLIC DISORDER, ANTIURICOPATHIC HOECHST AKTIENGESELLSCHAFT (DE) 1980-07-22 US disclosed
US-4152440-A DIURETICS, ANALGESICS HOECHST AKTIENGESELLSCHAFT (DE) 1979-05-01 US disclosed